Neonatal screening or Newborn Screening involves the screening of newborns in the first days of their lives for inborn errors of metabolism and certain disorders that can hinder the normal development of the baby. These disorders, are not apparent at the time of the baby's birth, but have potential to cause permanent neurological, cognitive, tactile and physical damage in the child. Early detection of such diseases enable initiating of suitable interventions to prevent concerning conditions in the long run. Trivitron provides a wide range Newborn Screening instruments, including Modular & Fully Automated NBS Instrumentation, manual & automated equipment and reagent kits. Trivitron's Diagnostic division Labsystems Diagnostics OY occupies the second place in the world when it comes to New Born Screening Technology.
Labsystems Diagnostics' Neonatal Biotinidase kit is for enzymatic determination of biotinidase enzyme activity from blood samples dried on filter paper, with fluorometric detection, intended for newborn screening for biotinidase deficiency.
Labsystems Diagnostics' Neonatal G6PD is an enzymatic method for the quantitative determination of glucose-6-phosphate dehydrogenase activity in blood samples dried on filter paper, with fluorometric detection, intended for newborn screening of glucose-6-phosphate dehydrogenase deficiency.
Labsystems Diagnostics' Neonatal Galactose is a quantitative fluorometric test for the total galactose from dried blood spot samples. The test is based on the combined determination of free and galactose liberated from the cleavage of the galactose-1-phosphate.
Labsystems Diagnostics' Neonatal Phenylalanine is a chemical method, with fluorometric detection, for quantitative determination of phenylalanine from blood specimens dried on filter paper, intended for newborn screening for phenylketonuria (PKU).